Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

about

Replication-competent adenovirus expressing TRAIL synergistically potentiates the antitumor effect of gemcitabine in bladder cancer cells.Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.

P2860

Q39017796-93B1B0C0-582F-4C1F-89E5-CD315556E335 Q53560998-455B9140-454C-4BDE-A8ED-03C4B814F51F

P2860

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

Item

http://www.wikidata.org/entity/Q36608713

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

@ast

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

@en

type

Item

label

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

@ast

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

@en

prefLabel

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

@ast

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

@en

P1476

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

@en

P2093

Ana Slipicevic

http://www.w3.org/2001/XMLSchema#string

Anne Katrine Ree Rosnes

http://www.w3.org/2001/XMLSchema#string

Birgit Engesæter

http://www.w3.org/2001/XMLSchema#string

Elisabeth Emilsen

http://www.w3.org/2001/XMLSchema#string

Geir Frode Øy

http://www.w3.org/2001/XMLSchema#string

Vivi Ann Flørenes

http://www.w3.org/2001/XMLSchema#string

Øystein Stakkestad

http://www.w3.org/2001/XMLSchema#string

P2860

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Melanoma: new insights and new therapies

A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesis

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

Garcinol potentiates TRAIL-induced apoptosis through modulation of death receptors and antiapoptotic proteins.

Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine.

New insights into apoptosis signaling by Apo2L/TRAIL.

Inhibitors of protein biosynthesis. II. Mode of action of anisomycin.

Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL

P304

146-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CBT.22953

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gunhild M. Mælandsmo

P577

2012-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233798089

http://www.w3.org/2001/XMLSchema#string

P698

23192275

http://www.w3.org/2001/XMLSchema#string

P921

anisomycin

P932

3571996

http://www.w3.org/2001/XMLSchema#string

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

about

P2860

P2860

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932